NEW YORK (GenomeWeb News) - Belgian company OncoMethylome Sciences has expanded its lab in Amsterdam by leasing an extra 1,000 square meters of lab space and hiring 10 new scientists.
The company said it expanded operations and personnel to support clinical trials for the its colorectal cancer program.
OncoMethylome is developing non-invasive molecular methylation screening tests that are performed on DNA from blood or stool samples. The research is supported by the Dutch Ministry of Economic Affairs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.